Therefore, we investigated the main question of our study: whether the extremely low activity of serum ALT is useful as a predictor of long-term overall-cause mortality in elderly patients undergoing percutaneous coronary intervention after acute coronary syndrome. This evidence concerns the gene GPT and acute coronary syndrome.